Company intelligence / Profile preview

Ariste Medical

Sandy, Utah, United States

Ownership: Private
Development stage: Other

Overview

Ariste Medical received FDA 510(k) clearance in March 2022 for an antibiotic-eluting polypropylene hernia mesh designed to reduce surgical site infections. The company has demonstrated proof-of-concept for applying its proprietary drug-coating technology to multiple material types (polypropylene, polyurethane, ePTFE, and metals) and various drug payloads including antibiotics and antiproliferative agents.

Therapeutic areas: CardiovascularNephrologyOtherGastroenterology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

University of Tennessee Research Foundation (exclusive licensee of underlying technology)

Beyond the preview

Go deeper on Ariste Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ariste Medical.

Explore the full profile